MDxHealth SA  

(Public, EBR:MDXH)   Watch this stock  
Find more results for Joseph Reyes�
-0.13 (-2.59%)
Mar 26 - Close
EBR real-time data - Disclaimer
Currency in EUR
Range 4.91 - 5.09
52 week 3.07 - 5.88
Open 5.09
Vol / Avg. 244,610.00/249,149.00
Mkt cap 186.07M
P/E     -
Div/yield     -
EPS -0.50
Shares 37.68M
Beta     -
Inst. own     -
May 29, 2015
MDxHealth SA Annual Shareholders Meeting (Estimated) - 10:00AM GMT+2 - Add to calendar
Mar 19, 2015
MDxHealth SA at The Wall Street Analyst Institutional Investor Conference

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -167.42% -214.12%
Operating margin -168.32% -212.75%
EBITD margin - -203.20%
Return on average assets -63.20% -65.57%
Return on average equity -78.19% -79.83%
Employees 84 -
CDP Score - -


CAP Business Center, Rue d'Abhooz, 31
+32-4-3642070 (Phone)
+32-4-3642071 (Fax)

Website links


MDxHealth SA is a Belgium-based company that develops and commercializes epigenetic assays and service testing for cancer assessment and the personalized treatment of patients. The Company�s offerings are structured into two divisions: Clinical Molecular Diagnostics (ClinicalMDx) solutions, providing physicians with tests which aid in the identification and treatment of their cancer patients, and Pharmaco Molecular Diagnostics (PharmacoMDx) solutions, collaborating with pharmaceutical companies on the development of companion diagnostics, biomarker discovery, and clinical trial testing. Its ClinicalMDx solutions include four different product types: ConfirmMDx, InformMDx, RecurMDx and PredictMDx. MDxHealth�s PharmacoMDx services, provided to both existing collaborators and on contracted services basis, focus on the identification and development of epigenetic biomarkers and molecular tests into companion diagnostics. The Company has one wholly owned subsidiary, MDxHealth Inc.

Officers and directors

Jan Groen Chief Executive Officer, Executive Director
Joseph Sollee Executive Vice President - Corporate Development and Legal Affairs
Age: 48
Christopher Thibodeau Executive Vice President of Commercial Operations
Age: 42
Wim van Criekinge Ph.D. Chief Scientific Officer
Francis Ota Executive Vice President - Finance
Age: 60
Miriam Reyes Vice President - Laboratory Operations
Joseph Bigley Vice President - Clinical Affairs
Ming-Chou Lee Ph.D. Vice President - Product Development
Edward L. Erickson Chairman, Non-Executive Independent Director
Age: 68
Rudi Marien Non-Executive Director, representing Gengest BVBA
Age: 69